Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 1,023,468 | 969,954 | -53,514 | $78.66M | $85.90M | 55.93% | +$7.24M |
| Springworks Therapeutics Inc | 254,773 | 531,351 | +276,578 | $9.20M | $23.45M | 15.27% | +$14.24M |
| Biohaven Ltd.(BHVN) | 851,770 | 665,945 | -185,825 | $31.81M | $16.01M | 10.42% | -$15.80M |
| Ardelyx Inc | 2,089,431 | 2,404,438 | +315,007 | $10.59M | $11.81M | 7.69% | +$1.21M |
| Teladoc Health, Inc.(TDOC) | 0 | 565,900 | +565,900 | $0 | $4.50M | 2.93% | +$4.50M |
| QuidelOrtho Corporation(QDEL) | 118,291 | 118,291 | 0 | $5.27M | $4.14M | 2.69% | -$1.13M |
| Forian Inc COM | 1,366,107 | 1,366,107 | 0 | $2.81M | $2.73M | 1.78% | -$82.0K |
| Palantir Technologies Inc.CL A(PLTR) | 28,500 | 29,500 | +1,000 | $2.16M | $2.49M | 1.62% | +$334.3K |
| CAVA Group, Inc.(CAVA) | 18,600 | 18,600 | 0 | $2.10M | $1.61M | 1.05% | -$490.9K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 0 | 120,000 | +120,000 | $0 | $634.8K | 0.41% | +$634.8K |
| Biogen Inc.(BIIB) | 2,412 | 2,412 | 0 | $368.8K | $330.1K | 0.21% | -$38.8K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 535,558 | 0 | -535,558 | $4.03M | $0 | — | -$4.03M |
| EyePoint, Inc.(EYPT) | 32,500 | 0 | -32,500 | $242.1K | $0 | — | -$242.1K |
| Pacific Biosciences of California, Inc.(PACB) | 279,638 | 0 | -279,638 | $511.7K | $0 | — | -$511.7K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 145,064 | 0 | -145,064 | $1.18M | $0 | — | -$1.18M |